Oshita F - Search Results

1

Serum levels of cytokines in patients with untreated primary lung cancer.

Katsumata N, Eguchi K, Fukuda M, Yamamoto N, Ohe Y, Oshita F, Tamura T, Shinkai T, Saijo N. Katsumata N, et al. Among authors: oshita f. Clin Cancer Res. 1996 Mar;2(3):553-9. Clin Cancer Res. 1996. PMID: 9816203

2

A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.

Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Miya T, Okamoto H, Iemura K, et al. Shinkai T, et al. Among authors: oshita f. Cancer Chemother Pharmacol. 1992;30(1):1-6. doi: 10.1007/BF00686477. Cancer Chemother Pharmacol. 1992. PMID: 1316809

3

A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.

Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Saijo N. Shinkai T, et al. Among authors: oshita f. Eur J Cancer. 1991;27(5):571-5. doi: 10.1016/0277-5379(91)90220-8. Eur J Cancer. 1991. PMID: 1647183 Clinical Trial.

4

Analysis of three-year survivors among patients with advanced inoperable non-small cell lung cancer.

Kojima A, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Oshita F, Miya T, Okamoto H, Kondo H, et al. Kojima A, et al. Among authors: oshita f. Jpn J Clin Oncol. 1991 Aug;21(4):276-81. Jpn J Clin Oncol. 1991. PMID: 1658415

5

Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer.

Eguchi K, Shinkai T, Sasaki Y, Tamura T, Ohe Y, Nakagawa K, Fukuda M, Yamada K, Kojima A, Oshita F, et al. Eguchi K, et al. Among authors: oshita f. Jpn J Cancer Res. 1990 Nov;81(11):1168-74. doi: 10.1111/j.1349-7006.1990.tb02530.x. Jpn J Cancer Res. 1990. PMID: 1702415 Free PMC article.

6

The frequency and management of infectious episodes and sepsis in small cell lung cancer patients receiving intensive chemotherapy with granulocyte-colony stimulating factor.

Oshita F, Tamura T, Okamoto H, Miya T, Kojima A, Ohe Y, Sasaki Y, Eguchi K, Shinkai T, Saijo N. Oshita F, et al. Jpn J Clin Oncol. 1991 Oct;21(5):353-9. Jpn J Clin Oncol. 1991. PMID: 1721656

7

Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer.

Ohe Y, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Nakagawa K, Kojima A, Yamada K, Oshita F, Miya T, et al. Ohe Y, et al. Among authors: oshita f. Jpn J Clin Oncol. 1990 Dec;20(4):364-8. Jpn J Clin Oncol. 1990. PMID: 2178196

8

Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patients.

Koga H, Eguchi K, Shinkai T, Tamura T, Ohe Y, Oshita F, Saijo N, Kondo H, Oki K, Okura H. Koga H, et al. Among authors: oshita f. Jpn J Clin Oncol. 1994 Oct;24(5):263-8. Jpn J Clin Oncol. 1994. PMID: 7526016

9

Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro.

Oshita F, Yamamoto N, Fukuda M, Ohe Y, Tamura T, Eguchi K, Shinkai T, Saijo N. Oshita F, et al. Cancer Res. 1995 Jun 1;55(11):2334-7. Cancer Res. 1995. PMID: 7757984 Clinical Trial.

10

The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.

Yamamoto N, Tamura T, Maeda M, Ando M, Shinkai T, Eguchi K, Ohe Y, Oshita F, Shiraishi J, Katsumata N, et al. Yamamoto N, et al. Among authors: oshita f. Cancer Chemother Pharmacol. 1995;36(2):102-6. doi: 10.1007/BF00689192. Cancer Chemother Pharmacol. 1995. PMID: 7767944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters